Dcf Advisers, LLC Evotec Se Transaction History
Dcf Advisers, LLC
- $242 Million
- Q3 2024
A detailed history of Dcf Advisers, LLC transactions in Evotec Se stock. As of the latest transaction made, Dcf Advisers, LLC holds 217,055 shares of EVO stock, worth $1.09 Million. This represents 0.33% of its overall portfolio holdings.
Number of Shares
217,055
Previous 114,953
88.82%
Holding current value
$1.09 Million
Previous $551,000
43.74%
% of portfolio
0.33%
Previous 0.3%
Shares
6 transactions
Others Institutions Holding EVO
# of Institutions
25Shares Held
3.42MCall Options Held
0Put Options Held
0-
Wellington Management Group LLP Boston, MA2.63MShares$13.2 Million0.0% of portfolio
-
Mediolanum International Funds LTD Dublin 1, L2140KShares$701,9150.01% of portfolio
-
Morgan Stanley New York, NY122KShares$612,2700.0% of portfolio
-
Black Rock Inc. New York, NY82.6KShares$412,9900.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny71KShares$355,0900.0% of portfolio
About Evotec SE
- Ticker EVO
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 353,904,992
- Market Cap $1.77B
- Description
- Evotec SE operates as drug discovery and development partner for the pharmaceutical and biotechnology industry worldwide. The company is developing pharmaceutical products in various therapeutic areas, such as diabetes and complications of diabetes, fibrosis, infectious diseases, CNS diseases, oncology, pain and inflammation, immunology, rare di...